Ophtesic (Anhydrous Lidocaine Hydrochloride)

Lidocaine hydrochloride blocks voltage‑gated sodium channels in the nerve fibers of the ocular surface. By preventing sodium influx, it stops the generation and propagation of nerve impulses, resulting in localized loss of sensation without affecting deeper ocular structures.

The specific dose and volume of Ophtesic are determined by the prescribing clinician based on the procedure, patient age, and ocular condition. Healthcare professionals should follow the product label and clinical guidelines when selecting the appropriate amount.

Safety data for Ophtesic in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and after a thorough assessment by the prescriber.

To order Ophtesic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ophtesic contains lidocaine, an amide‑type local anesthetic, offering rapid onset and reliable surface numbness. Compared with ester‑type agents such as proparacaine, lidocaine generally provides a slightly longer duration of anesthesia but shares a similar safety profile when used correctly.

Ophtesic should be stored at room temperature, below 25 °C, in its original sealed container. Protect the product from direct sunlight, moisture and extreme temperatures to maintain sterility and potency.

Ophtesic is applied topically to the ocular surface as a sterile drop. The prescriber determines the number of drops and timing based on the intended procedure. Patients should avoid touching the dropper tip to the eye or surrounding tissues to preserve sterility.

Serious risks, though rare, include corneal epithelial toxicity, severe allergic reactions such as anaphylaxis, persistent visual disturbances, and secondary ocular infection. Immediate medical attention is required if any of these events occur.

Ophtesic should not be used in individuals with a known hypersensitivity to lidocaine, other amide anesthetics, or any component of the formulation. Caution is also advised for patients with significant cardiac conduction disorders or compromised corneal epithelium.